Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

First Ten-Year Follow-Up Shows That Treatment With AVONEX® Leads To Long-Term Benefits In Early Multiple Sclerosis Patients
Biogen Idec (NASDAQ: BIIB) announced data results from the CHAMPIONS (Controlled High-Risk AVONEX® (interferon beta-1a) Multiple Sclerosis (MS) Prevention Study In Ongoing Neurologic Surveillance) study, an open label follow-up to CHAMPS (Controlled High Risk Subjects AVONEX MS Prevention Study). Based on the CHAMPS study, AVONEX was granted approval for use in patients who experienced their first clinical MS episode with MRI findings. The CHAMPIONS ten-year follow up showed that patients treated immediately after their first episode had significantly less chance of experiencing a second attack versus those patients with delayed treatment. These results at ten years also indicate that 80 percent of patients taking AVONEX were below an expanded disability status scale (EDSS) score of three. These data were presented as a poster at the Annual American Academy of Neurology (AAN) meeting.
generic viagra online
Financial Crisis Caused By Banking Chiefs Plagued With Hubris Syndrome
The current financial meltdown has in part been caused by bankers who display the attributes of Hubris Syndrome, a former leader of the Social Democratic Party (SDP) has claimed.
News of the day
Man Charged With Murder Of Abortion Provider Tiller Pleads Not Guilty
Scott Roeder, the man charged with the May 31 shooting death of abortion provider George Tiller, pleaded not guilty to first-degree murder and aggravated assault at a Wichita, Kan., hearing on Tuesday, the AP/Boston Globe reports (AP/Boston Globe, 7/29). After witnesses described events surrounding the shooting, the judge presiding over the hearing concluded that there was sufficient evidence to try Roeder. Tiller was murdered in the foyer of his church, where he was serving as an usher. According to several church members who testified Tuesday, Roeder occasionally had come to the church in the months before the shooting.The trial is scheduled to begin Sept. 21 (Davey, New York Times, 7/28). At the hearing, Roeder made no public comments, and the not-guilty plea was entered by the public defender representing him in the case (AP/Boston Globe, 7/29).If convicted, Roeder likely will face life in prison, as the case does not meet state criteria for the death penalty. His lawyers declined to comment on their defense plans (New York Times, 7/28).
Endocrinology

UQ Scientist's Outstanding Pain Management Research Recognised

A UQ Science researcher has received a prestigious honorary fellowship for her long-time work into understanding the underlying mechanisms of pain. Professor Maree Smith has been awarded the Honorary Fellowship by the Australian and New Zealand College of Anaesthetists" Faculty of Pain Medicine. The Faculty of Pain Medicine admits distinguished persons who have made a notable contribution to the advancement of the science and practice of pain medicine, but are not practising pain medicine in Australia or New Zealand. Executive Director of UQ"s Centre for Integrated Preclinical Drug Development and its commercial arm, TetraQ, Professor Smith said she was very surprised to be honoured. "When I got the letter and opened it, I just thought "wow", I didn"t even know they did this," she said. "I feel really flattered and honoured, my research team and I have been working away in the field for about two decades now because that"s what you need to do in order to make a difference, I never expected to get recognised for it." Pain medicine is a multidisciplinary field of specialist medical practice that has matured relatively recently. The field recognises the management of severe pain problems requires the skills of more than one medical discipline. Professor Smith has specialist expertise in pre-clinical drug development as well as the mechanistic basis of pain and its pharmacological management. As TetraQ CEO, a leading Australian preclinical drug development contract research organisation based at UQ, Professor Smith is in a unique position to further pain medicine. "At TetraQ we sit in the translational research space," she said. "We assist universities and small biotech and pharmaceutical companies in getting potential drugs from the laboratory bench to the pharmacy. "We perform the preclinical drug trials, showing these drugs are efficacious - they do what the company says they do - and that they are safe to go on to human trials." This isn"t the first award Professor Smith has received for her contributions to science, in 2008 she received the Women in Technology Biotech Outstanding Achievement Award. And in 2003, Professor Smith was awarded a "Trailblazer Challenge" award by UniQuest, for developing new treatments for the pain caused by sciatica and other forms of nerve damage. The FPM is the body responsible for training, education and standards for Pain Medicine in Australia and New Zealand. The University of Queensland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009